1,153.32
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NFLX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1,162.53
Offen:
$1165
24-Stunden-Volumen:
3.06M
Relative Volume:
0.97
Marktkapitalisierung:
$490.08B
Einnahmen:
$41.46B
Nettoeinkommen (Verlust:
$10.25B
KGV:
49.15
EPS:
23.466
Netto-Cashflow:
$8.50B
1W Leistung:
-4.73%
1M Leistung:
-5.94%
6M Leistung:
+25.76%
1J Leistung:
+63.17%
Netflix Inc Stock (NFLX) Company Profile
Firmenname
Netflix Inc
Sektor
Branche
Telefon
408-540-3700
Adresse
121 ALBRIGHT WAY, LOS GATOS
Vergleichen Sie NFLX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
NFLX
Netflix Inc
|
1,153.32 | 493.99B | 41.46B | 10.25B | 8.50B | 23.47 |
![]()
DIS
Walt Disney Co
|
112.47 | 201.62B | 94.13B | 12.55B | 11.55B | 6.3783 |
![]()
WBD
Warner Bros Discovery Inc
|
18.99 | 47.63B | 38.41B | 640.00M | 4.07B | 0.302 |
![]()
LYV
Live Nation Entertainment Inc
|
156.32 | 36.34B | 23.72B | 775.11M | 1.08B | 2.3024 |
![]()
FWONK
Liberty Media Corp
|
104.83 | 26.04B | 3.51B | -102.00M | 737.00M | -0.42 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-09-17 | Hochstufung | Loop Capital | Hold → Buy |
2025-07-10 | Bestätigt | KeyBanc Capital Markets | Overweight |
2025-07-07 | Herabstufung | Seaport Research Partners | Buy → Neutral |
2025-07-02 | Bestätigt | Canaccord Genuity | Buy |
2025-07-02 | Bestätigt | Goldman | Neutral |
2025-06-20 | Bestätigt | Pivotal Research Group | Buy |
2025-06-12 | Bestätigt | Oppenheimer | Outperform |
2025-06-03 | Bestätigt | Jefferies | Buy |
2025-05-30 | Bestätigt | BofA Securities | Buy |
2025-05-19 | Herabstufung | JP Morgan | Overweight → Neutral |
2025-04-21 | Bestätigt | BMO Capital Markets | Outperform |
2025-04-21 | Bestätigt | Barclays | Equal Weight |
2025-04-21 | Bestätigt | Canaccord Genuity | Buy |
2025-04-21 | Bestätigt | Guggenheim | Buy |
2025-04-21 | Bestätigt | JP Morgan | Overweight |
2025-04-21 | Bestätigt | KeyBanc Capital Markets | Overweight |
2025-04-21 | Bestätigt | MoffettNathanson | Buy |
2025-04-21 | Bestätigt | Morgan Stanley | Overweight |
2025-04-21 | Bestätigt | Oppenheimer | Outperform |
2025-04-21 | Bestätigt | Piper Sandler | Overweight |
2025-04-21 | Bestätigt | Pivotal Research Group | Buy |
2025-04-21 | Bestätigt | Wells Fargo | Overweight |
2025-04-17 | Fortgesetzt | Piper Sandler | Overweight |
2025-03-27 | Eingeleitet | FBN Securities | Outperform |
2025-03-17 | Hochstufung | MoffettNathanson | Neutral → Buy |
2025-01-24 | Hochstufung | Bernstein | Mkt Perform → Outperform |
2025-01-23 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2025-01-22 | Hochstufung | Barclays | Underweight → Equal Weight |
2025-01-22 | Hochstufung | Canaccord Genuity | Hold → Buy |
2025-01-22 | Bestätigt | Oppenheimer | Outperform |
2025-01-22 | Bestätigt | Pivotal Research Group | Buy |
2025-01-22 | Hochstufung | Rosenblatt | Neutral → Buy |
2025-01-22 | Hochstufung | The Benchmark Company | Sell → Hold |
2025-01-16 | Hochstufung | Seaport Research Partners | Neutral → Buy |
2025-01-15 | Bestätigt | BMO Capital Markets | Outperform |
2025-01-15 | Bestätigt | Oppenheimer | Outperform |
2025-01-08 | Bestätigt | Goldman | Neutral |
2025-01-06 | Bestätigt | Argus | Buy |
2025-01-03 | Bestätigt | The Benchmark Company | Sell |
2024-12-19 | Bestätigt | UBS | Buy |
2024-12-16 | Herabstufung | Loop Capital | Buy → Hold |
2024-12-16 | Bestätigt | Oppenheimer | Outperform |
2024-12-11 | Bestätigt | JP Morgan | Overweight |
2024-11-20 | Bestätigt | Pivotal Research Group | Buy |
2024-10-18 | Bestätigt | Needham | Buy |
2024-10-18 | Bestätigt | Oppenheimer | Outperform |
2024-10-18 | Bestätigt | Pivotal Research Group | Buy |
2024-10-16 | Bestätigt | Loop Capital | Buy |
2024-10-11 | Bestätigt | Guggenheim | Buy |
2024-10-10 | Bestätigt | Morgan Stanley | Overweight |
2024-10-10 | Bestätigt | Oppenheimer | Outperform |
2024-10-07 | Herabstufung | Barclays | Equal Weight → Underweight |
2024-10-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
2024-10-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-09-05 | Eingeleitet | China Renaissance | Hold |
2024-08-30 | Bestätigt | Pivotal Research Group | Buy |
2024-07-17 | Bestätigt | Guggenheim | Buy |
2024-07-16 | Bestätigt | The Benchmark Company | Sell |
2024-07-15 | Bestätigt | BofA Securities | Buy |
2024-07-12 | Bestätigt | JP Morgan | Overweight |
2024-07-10 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-07-09 | Bestätigt | TD Cowen | Buy |
2024-07-02 | Bestätigt | Argus | Buy |
2024-05-28 | Bestätigt | Evercore ISI | Outperform |
2024-04-19 | Herabstufung | Canaccord Genuity | Buy → Hold |
2024-04-19 | Hochstufung | Needham | Hold → Buy |
2024-04-19 | Bestätigt | Pivotal Research Group | Buy |
2024-04-15 | Bestätigt | Deutsche Bank | Hold |
2024-04-12 | Bestätigt | Morgan Stanley | Overweight |
2024-04-12 | Bestätigt | Piper Sandler | Neutral |
2024-04-05 | Bestätigt | Pivotal Research Group | Buy |
2024-03-25 | Bestätigt | Citigroup | Neutral |
2024-03-12 | Bestätigt | Jefferies | Buy |
2024-03-11 | Bestätigt | Oppenheimer | Outperform |
2024-01-30 | Herabstufung | Seaport Research Partners | Buy → Neutral |
2024-01-25 | Hochstufung | DZ Bank | Hold → Buy |
2024-01-24 | Bestätigt | BMO Capital Markets | Outperform |
2024-01-24 | Bestätigt | BofA Securities | Buy |
2024-01-24 | Bestätigt | Canaccord Genuity | Buy |
2024-01-24 | Bestätigt | Evercore ISI | Outperform |
2024-01-24 | Bestätigt | Goldman | Neutral |
2024-01-24 | Bestätigt | Guggenheim | Buy |
2024-01-24 | Bestätigt | JP Morgan | Overweight |
2024-01-24 | Bestätigt | KeyBanc Capital Markets | Overweight |
2024-01-24 | Hochstufung | Macquarie | Neutral → Outperform |
2024-01-24 | Bestätigt | Morgan Stanley | Overweight |
2024-01-24 | Bestätigt | Oppenheimer | Outperform |
2024-01-24 | Bestätigt | Piper Sandler | Neutral |
2024-01-24 | Bestätigt | Pivotal Research Group | Buy |
2024-01-24 | Bestätigt | Redburn Atlantic | Buy |
2024-01-24 | Bestätigt | Robert W. Baird | Outperform |
2024-01-24 | Bestätigt | TD Cowen | Outperform |
2024-01-24 | Bestätigt | UBS | Buy |
2024-01-24 | Bestätigt | Wells Fargo | Overweight |
2023-09-18 | Bestätigt | Evercore ISI | Outperform |
2023-08-25 | Hochstufung | Loop Capital | Hold → Buy |
2023-07-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2023-07-17 | Bestätigt | Deutsche Bank | Buy |
2023-07-13 | Bestätigt | JP Morgan | Overweight |
2023-07-12 | Bestätigt | UBS | Buy |
2023-07-05 | Hochstufung | Goldman | Sell → Neutral |
2023-06-29 | Bestätigt | Citigroup | Buy |
2023-06-28 | Bestätigt | Oppenheimer | Outperform |
2023-06-13 | Bestätigt | BofA Securities | Buy |
2023-06-13 | Bestätigt | Guggenheim | Buy |
2023-04-19 | Bestätigt | Deutsche Bank | Buy |
2023-04-19 | Bestätigt | JP Morgan | Overweight |
2023-04-19 | Bestätigt | Jefferies | Buy |
2023-04-19 | Bestätigt | Piper Sandler | Neutral |
2023-04-19 | Bestätigt | Pivotal Research Group | Buy |
2023-04-19 | Bestätigt | Rosenblatt | Neutral |
2023-04-19 | Hochstufung | UBS | Neutral → Buy |
2023-04-11 | Fortgesetzt | Robert W. Baird | Neutral |
2023-01-23 | Bestätigt | Argus | Buy |
2023-01-20 | Bestätigt | Canaccord Genuity | Buy |
2023-01-20 | Bestätigt | Deutsche Bank | Buy |
2023-01-20 | Bestätigt | Evercore ISI | Outperform |
2023-01-20 | Bestätigt | Goldman | Sell |
2023-01-20 | Bestätigt | Guggenheim | Buy |
2023-01-20 | Bestätigt | Jefferies | Buy |
2023-01-20 | Bestätigt | MoffettNathanson | Market Perform |
2023-01-20 | Bestätigt | Oppenheimer | Outperform |
2023-01-20 | Bestätigt | Piper Sandler | Neutral |
2023-01-20 | Bestätigt | Pivotal Research Group | Buy |
2023-01-20 | Bestätigt | Robert W. Baird | Neutral |
2023-01-20 | Bestätigt | The Benchmark Company | Sell |
2023-01-20 | Bestätigt | Wedbush | Outperform |
2023-01-20 | Bestätigt | Wolfe Research | Outperform |
2023-01-12 | Hochstufung | Jefferies | Hold → Buy |
2023-01-04 | Eingeleitet | New Street | Neutral |
2022-12-29 | Hochstufung | CFRA | Sell → Buy |
2022-12-14 | Bestätigt | Jefferies | Hold |
2022-12-09 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2022-06-14 | Herabstufung | The Benchmark Company | Hold → Sell |
2022-06-10 | Herabstufung | Goldman | Neutral → Sell |
2022-05-16 | Hochstufung | Wedbush | Neutral → Outperform |
2022-04-21 | Herabstufung | DZ Bank | Buy → Hold |
2022-04-21 | Herabstufung | Edward Jones | Buy → Hold |
2022-04-20 | Herabstufung | Atlantic Equities | Overweight → Neutral |
2022-04-20 | Herabstufung | BofA Securities | Buy → Underperform |
2022-04-20 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-04-20 | Hochstufung | Needham | Underperform → Hold |
2022-04-20 | Herabstufung | Oppenheimer | Outperform → Perform |
2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
2022-04-20 | Herabstufung | Pivotal Research Group | Buy → Sell |
2022-04-20 | Herabstufung | Stifel | Buy → Hold |
2022-04-20 | Herabstufung | UBS | Buy → Neutral |
2022-04-20 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2022-04-19 | Eingeleitet | Rosenblatt | Neutral |
2022-03-09 | Hochstufung | Wedbush | Underperform → Neutral |
2022-01-31 | Hochstufung | Citigroup | Neutral → Buy |
2022-01-31 | Hochstufung | Edward Jones | Hold → Buy |
2022-01-24 | Herabstufung | Jefferies | Buy → Hold |
2022-01-21 | Bestätigt | BMO Capital Markets | Outperform |
2022-01-21 | Bestätigt | BofA Securities | Buy |
2022-01-21 | Bestätigt | Canaccord Genuity | Buy |
2022-01-21 | Bestätigt | Cowen | Outperform |
2022-01-21 | Bestätigt | Deutsche Bank | Hold |
2022-01-21 | Bestätigt | Goldman | Neutral |
2022-01-21 | Bestätigt | Guggenheim | Buy |
2022-01-21 | Bestätigt | JP Morgan | Overweight |
2022-01-21 | Bestätigt | MoffettNathanson | Neutral |
2022-01-21 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
2022-01-21 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2022-01-21 | Bestätigt | Oppenheimer | Outperform |
2022-01-21 | Bestätigt | Piper Sandler | Overweight |
2022-01-21 | Bestätigt | Pivotal Research Group | Buy |
2022-01-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2022-01-21 | Bestätigt | Stifel | Buy |
2022-01-21 | Hochstufung | The Benchmark Company | Sell → Hold |
2022-01-21 | Herabstufung | Truist | Buy → Hold |
2022-01-21 | Bestätigt | UBS | Buy |
2022-01-21 | Bestätigt | Wolfe Research | Outperform |
2021-12-15 | Bestätigt | The Benchmark Company | Sell |
2021-10-20 | Herabstufung | Deutsche Bank | Buy → Hold |
2021-10-20 | Bestätigt | Monness Crespi & Hardt | Buy |
2021-09-29 | Bestätigt | The Benchmark Company | Sell |
2021-09-13 | Eingeleitet | Goldman | Neutral |
2021-09-08 | Bestätigt | JP Morgan | Overweight |
2021-09-07 | Bestätigt | Atlantic Equities | Overweight |
2021-07-21 | Bestätigt | Credit Suisse | Outperform |
2021-07-21 | Bestätigt | Deutsche Bank | Buy |
2021-07-21 | Bestätigt | JP Morgan | Overweight |
2021-07-21 | Bestätigt | KeyBanc Capital Markets | Overweight |
2021-07-21 | Bestätigt | Stifel | Buy |
2021-06-25 | Hochstufung | Credit Suisse | Neutral → Outperform |
2021-06-25 | Eingeleitet | Edward Jones | Hold |
2021-05-19 | Fortgesetzt | Jefferies | Buy |
2021-04-21 | Fortgesetzt | Oppenheimer | Outperform |
2021-04-21 | Bestätigt | Pivotal Research Group | Buy |
2021-04-21 | Hochstufung | Stifel | Hold → Buy |
2021-04-06 | Fortgesetzt | Evercore ISI | Outperform |
2021-04-01 | Eingeleitet | Piper Sandler | Overweight |
2021-03-25 | Bestätigt | The Benchmark Company | Sell |
2021-03-23 | Hochstufung | Argus | Hold → Buy |
2021-01-21 | Hochstufung | DZ Bank | Hold → Buy |
2021-01-20 | Bestätigt | Monness Crespi & Hardt | Buy |
2021-01-20 | Bestätigt | Pivotal Research Group | Buy |
2021-01-20 | Bestätigt | The Benchmark Company | Sell |
2021-01-20 | Hochstufung | UBS | Neutral → Buy |
2021-01-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
2020-10-21 | Bestätigt | BMO Capital Markets | Outperform |
2020-10-21 | Bestätigt | Bernstein | Outperform |
2020-10-21 | Bestätigt | Jefferies | Buy |
2020-10-21 | Bestätigt | Morgan Stanley | Overweight |
2020-10-21 | Bestätigt | Oppenheimer | Outperform |
2020-10-21 | Bestätigt | Piper Sandler | Overweight |
2020-10-21 | Bestätigt | Pivotal Research Group | Buy |
2020-10-21 | Bestätigt | RBC Capital Mkts | Outperform |
2020-10-21 | Bestätigt | The Benchmark Company | Sell |
2020-10-21 | Bestätigt | Wedbush | Underperform |
2020-10-21 | Bestätigt | Wells Fargo | Equal Weight |
2020-10-16 | Bestätigt | Morgan Stanley | Overweight |
2020-10-15 | Bestätigt | Canaccord Genuity | Buy |
2020-10-14 | Bestätigt | Goldman | Buy |
2020-10-07 | Bestätigt | Pivotal Research Group | Buy |
2020-09-28 | Bestätigt | The Benchmark Company | Sell |
2020-09-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
2020-09-09 | Fortgesetzt | Raymond James | Mkt Perform |
2020-09-04 | Bestätigt | The Benchmark Company | Sell |
2020-07-29 | Bestätigt | Loop Capital | Buy |
Alle ansehen
Netflix Inc Aktie (NFLX) Neueste Nachrichten
The Trade Desk Is a Great Company, But I'm Not Buying the Stock Yet - The Motley Fool
Three Bridge Wealth Advisors LLC Acquires New Position in Netflix, Inc. $NFLX - MarketBeat
Merit Financial Group LLC Grows Position in Netflix, Inc. $NFLX - MarketBeat
Marietta Wealth Management LLC Decreases Stock Holdings in Netflix, Inc. $NFLX - MarketBeat
Kercheville Advisors LLC Increases Stock Holdings in Netflix, Inc. $NFLX - MarketBeat
Netflix, Inc. $NFLX Shares Acquired by Simplicity Wealth LLC - MarketBeat
OLD National Bancorp IN Acquires 8,666 Shares of Netflix, Inc. $NFLX - MarketBeat
Netflix, Inc. $NFLX Shares Acquired by Brown Miller Wealth Management LLC - MarketBeat
Netflix vs Elon Musk: Streaming platform shares fall 5% in a week; here's why Tesla CEO is not watching i - Times of India
Hill Island Financial LLC Takes $301,000 Position in Netflix, Inc. $NFLX - MarketBeat
Talbot Financial LLC Has $22.74 Million Position in Netflix, Inc. $NFLX - MarketBeat
Elon Musk wants us to cancel Netflix over a trans character. I don't blame him. | Opinion - USA Today
Netflix, Inc. $NFLX Shares Sold by Ameritas Advisory Services LLC - MarketBeat
Penobscot Investment Management Company Inc. Invests $410,000 in Netflix, Inc. $NFLX - MarketBeat
NTV Asset Management LLC Takes $492,000 Position in Netflix, Inc. $NFLX - MarketBeat
Netflix cap drops around $15 billion after Elon Musk's boycott call - India Today
How Netflix Inc. (NFLX) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Beyond Streaming: Netflix's Quiet Moves Into Gaming and Live Experiences - The Motley Fool
'House of Guinness' creator Steven Knight spills the tea on the new Netflix series - NPR
AMF Tjanstepension AB Has $142.64 Million Holdings in Netflix, Inc. $NFLX - MarketBeat
Netflix, Inc. $NFLX Shares Purchased by Sava Infond d.o.o. - MarketBeat
LGT Fund Management Co Ltd. Purchases 1,135 Shares of Netflix, Inc. $NFLX - MarketBeat
Forget Netflix and Disney. This Is the Sleeper Streaming Stock You Should Be Buying - 24/7 Wall St.
Hudson Valley Investment Advisors Inc. ADV Buys Shares of 4,450 Netflix, Inc. $NFLX - MarketBeat
Netflix, Inc. $NFLX Shares Sold by 111 Capital - MarketBeat
QRG Capital Management Inc. Boosts Stake in Netflix, Inc. $NFLX - MarketBeat
Shai Gilgeous-Alexander to feature in Netflix docuseries. What we know about 'Starting 5' season 2. - The Oklahoman
Fortis Capital Advisors LLC Increases Holdings in Netflix, Inc. $NFLX - MarketBeat
Precedent Wealth Partners LLC Invests $316,000 in Netflix, Inc. $NFLX - MarketBeat
Consolidated Investment Group LLC Sells 800 Shares of Netflix, Inc. $NFLX - MarketBeat
Franklin Street Advisors Inc. NC Makes New $698,000 Investment in Netflix, Inc. $NFLX - MarketBeat
Netflix, Inc. $NFLX Shares Bought by Fairvoy Private Wealth LLC - MarketBeat
Netflix, Inc. $NFLX Shares Bought by Ascent Group LLC - MarketBeat
Triad Wealth Partners LLC Buys Shares of 278 Netflix, Inc. $NFLX - MarketBeat
3 Things to Know About Netflix Stock Before You Buy - AOL.com
Netflix executive's pro-transgender social media posts surface during kid's content controversy - Yahoo
Netflix's Yellowstone Replacement Series Stars Gillian Anderson And Lena Headey (And It's Coming Soon) - IMDb
Musk and Trump Fight Over Who’s the Bigger Threat to Netflix Stock (NFLX) - TipRanks
The Twits Movie: Release Date, Cast, Plot, and All You Need to Know - IMDb
Netflix Stock Drops Following Boycott Over Trans Content For Kids - Facebook
Netflix stock logs biggest weekly drop since April as Elon Musk calls for users to cancel subscriptions - Yahoo Finance
Billions Lost: Netflix Boycotts Over Trans Kids’ Shows Spark Culture War And Stock Drop - Black Westchester
Netflix stock on track to end week down 5% as Elon Musk calls for users to cancel subscriptions - Yahoo Finance
Netflix analysts cautious ahead of Q3 results - Proactive financial news
'The Body' Cast For Quinn Shephard Netflix Series Unveiled - deadline.com
Netflix stock defended at Oppenheimer amid recent underperformance - Investing.com
Netflix will focus on generative AI for its future games - Instant Gaming News
Netflix, Inc. (NFLX) Stock: Musk’s Cancel Campaign Joins Wider Criticism, Shares Fall Almost 5% - CoinCentral
Elon Musk Vows to “Cancel” Netflix Over Transgender Representation - Vanity Fair
Is 'Love Is Blind' still casting singles in Ohio? What we know as Season 9 airs on Netflix - The Columbus Dispatch
Citigroup Issues Pessimistic Forecast for Netflix (NASDAQ:NFLX) Stock Price - MarketBeat
Finanzdaten der Netflix Inc-Aktie (NFLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):